Literature DB >> 20156849

Effects of substitution of Cx43 by Cx32 on myocardial energy metabolism, tolerance to ischaemia and preconditioning protection.

Antonio Rodríguez-Sinovas1, Jose A Sánchez, Alejandra González-Loyola, Ignasi Barba, Miriam Morente, Rio Aguilar, Esperanza Agulló, Elisatet Miró-Casas, Neus Esquerda, Marisol Ruiz-Meana, David García-Dorado.   

Abstract

Connexin 43 (Cx43) plays an important role in cardioprotective signalling by mechanisms at least in part independent of gap junctional communication. To investigate whether this role is related to specific properties of this connexin isoform, we used a knock-in mouse model in which the coding region of Cx43 is replaced by that of Cx32. Homozygous Cx43KI32 mice showed reduced cell-to-cell Lucifer Yellow transfer (P < 0.01), but QRS duration and left ventricular fractional shortening (echocardiography) were similar to those in wild-type animals. NMR spectroscopy detected reduced ATP and increased lactate content in myocardium from homozygous Cx43KI32 animals (P < 0.05). Despite this, isolated homozygous Cx43KI32 hearts showed smaller infarcts after ischaemia-reperfusion (40 min/60 min) as compared to hearts from heterozygous and wild-type animals (13 and 31% reduction, respectively, P < 0.05). Cardiac myocytes isolated from Cx43KI32 mouse hearts also showed a reduced rate of cell death after simulated ischaemia-reperfusion. In a separate series of experiments, both ischaemic (4 cycles of 3.5 min of ischaemia and 5 min of reperfusion) and pharmacological (50 micromol l(-1) diazoxide, 10 min) preconditioning reduced infarct size in hearts from wild-type mice (by 24.84 and 26.63%, respectively, P < 0.05), but only ischaemic preconditioning was effective in hearts from heterozygous animals and both preconditioning strategies failed to protect Cx43KI32 homozygous hearts. These results demonstrate that Cx43 has an important and previously unknown modulatory effect in myocardial energy metabolism and tolerance to ischaemia, and plays a critical role in preconditioning protection, by mechanisms that are specific for this connexin isoform.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156849      PMCID: PMC2853001          DOI: 10.1113/jphysiol.2009.186577

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  36 in total

Review 1.  Connexins and impulse propagation in the mouse heart.

Authors:  J Jalife; G E Morley; D Vaidya
Journal:  J Cardiovasc Electrophysiol       Date:  1999-12

Review 2.  Cardiac connexins and impulse propagation.

Authors:  John A Jansen; Toon A B van Veen; Jacques M T de Bakker; Harold V M van Rijen
Journal:  J Mol Cell Cardiol       Date:  2009-08-31       Impact factor: 5.000

3.  Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium.

Authors:  Javier Inserte; Ignasi Barba; Víctor Hernando; David Garcia-Dorado
Journal:  Cardiovasc Res       Date:  2008-10-01       Impact factor: 10.787

4.  Amino acid transamination is crucial for ischaemic cardioprotection in normal and preconditioned isolated rat hearts--focus on L-glutamate.

Authors:  Bo Løfgren; Jonas Agerlund Povlsen; Lars Ege Rasmussen; Nicolaj Brejnholt Støttrup; Lasse Solskov; Peter-Martin Krarup; Steen Buus Kristiansen; Hans Erik Bøtker; Torsten Toftegaard Nielsen
Journal:  Exp Physiol       Date:  2009-08-28       Impact factor: 2.969

5.  Protective role of gap junctions in preconditioning against myocardial infarction.

Authors:  Tetsuji Miura; Yoshito Ohnuma; Atsushi Kuno; Masaya Tanno; Yoshihiko Ichikawa; Yuichi Nakamura; Toshiyuki Yano; Takayuki Miki; Jun Sakamoto; Kazuaki Shimamoto
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-09-18       Impact factor: 4.733

6.  Reversible blockade of electron transport with amobarbital at the onset of reperfusion attenuates cardiac injury.

Authors:  Sarah Stewart; Edward J Lesnefsky; Qun Chen
Journal:  Transl Res       Date:  2009-03-12       Impact factor: 7.012

7.  Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy.

Authors:  Marie A Schroeder; Helen J Atherton; Daniel R Ball; Mark A Cole; Lisa C Heather; Julian L Griffin; Kieran Clarke; George K Radda; Damian J Tyler
Journal:  FASEB J       Date:  2009-03-27       Impact factor: 5.191

Review 8.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

9.  Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43.

Authors:  Gang Lu; Husnain K Haider; Shujia Jiang; Muhammad Ashraf
Journal:  Circulation       Date:  2009-05-04       Impact factor: 29.690

10.  Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake.

Authors:  Elisabet Miro-Casas; Marisol Ruiz-Meana; Esperanza Agullo; Sabine Stahlhofen; Antonio Rodríguez-Sinovas; Alberto Cabestrero; Inmaculada Jorge; Iratxe Torre; Jesus Vazquez; Kerstin Boengler; Rainer Schulz; Gerd Heusch; David Garcia-Dorado
Journal:  Cardiovasc Res       Date:  2009-05-21       Impact factor: 10.787

View more
  18 in total

Review 1.  Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease.

Authors:  Antonio Rodríguez-Sinovas; Jose Antonio Sánchez; Laura Valls-Lacalle; Marta Consegal; Ignacio Ferreira-González
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 2.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

3.  Mitochondria-specific transgenic overexpression of connexin-43 simulates preconditioning-induced cytoprotection of stem cells.

Authors:  Gang Lu; Husnain Kh Haider; Aleksey Porollo; Muhammad Ashraf
Journal:  Cardiovasc Res       Date:  2010-09-10       Impact factor: 10.787

Review 4.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

5.  Expression of skeletal muscle sodium channel (Nav1.4) or connexin32 prevents reperfusion arrhythmias in murine heart.

Authors:  Evgeny P Anyukhovsky; Eugene A Sosunov; Yelena N Kryukova; Kevin Prestia; Nazira Ozgen; Mathilde Rivaud; Ira S Cohen; Richard B Robinson; Michael R Rosen
Journal:  Cardiovasc Res       Date:  2010-09-07       Impact factor: 10.787

6.  Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction.

Authors:  Ian D Greener; Tetsuo Sasano; Xiaoping Wan; Tomonori Igarashi; Maria Strom; David S Rosenbaum; J Kevin Donahue
Journal:  J Am Coll Cardiol       Date:  2012-08-08       Impact factor: 24.094

7.  Stress response protein GJA1-20k promotes mitochondrial biogenesis, metabolic quiescence, and cardioprotection against ischemia/reperfusion injury.

Authors:  Wassim A Basheer; Ying Fu; Daisuke Shimura; Shaohua Xiao; Sosse Agvanian; Diana M Hernandez; Tara C Hitzeman; TingTing Hong; Robin M Shaw
Journal:  JCI Insight       Date:  2018-10-18

Review 8.  Paracrine signaling through plasma membrane hemichannels.

Authors:  Nan Wang; Marijke De Bock; Elke Decrock; Mélissa Bol; Ashish Gadicherla; Mathieu Vinken; Vera Rogiers; Feliksas F Bukauskas; Geert Bultynck; Luc Leybaert
Journal:  Biochim Biophys Acta       Date:  2012-07-13

9.  Increased Cell-Cell Coupling Increases Infarct Size and Does not Decrease Incidence of Ventricular Tachycardia in Mice.

Authors:  Kevin A Prestia; Eugene A Sosunov; Evgeny P Anyukhovsky; Elena Dolmatova; Caitlin W Kelly; Peter R Brink; Richard B Robinson; Michael R Rosen; Heather S Duffy
Journal:  Front Physiol       Date:  2011-01-31       Impact factor: 4.566

10.  Connexin diversity in the heart: insights from transgenic mouse models.

Authors:  Sander Verheule; Sven Kaese
Journal:  Front Pharmacol       Date:  2013-06-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.